Jeffrey Collins
Listed on 1 Form D filing across 1+ issuer
· Executive Officer
Associated issuers
- Uvantis Therapeutics, Inc. CIK 2156954 · MD
Filings (1)
-
Uvantis Therapeutics, Inc.D · Sep 23, 2026 · MD · Biotechnology$5MView filing →